Published Date: 30-Nov-2019
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Smart Biopsy Market, published by KBV Research, The Global Smart Biopsy Market size is expected to reach $3.2 billion by 2025, rising at a market growth of 5.3% CAGR during the forecast period.
In the application segment, breast cancer sub-segment dominated the market in 2018. The reason being, it's the most common cancer diagnosed among women over the age of 45. This cancer grows either in lobules (glands that produce milk) or in ducts that usually form in breast cells. The Skin cancer market is anticipated to grow at a CAGR of 5.8% during (2019 - 2025). The Prostate cancer market is poised to grow at a CAGR of 6.26% during the forecast period.
North America dominated the smart biopsy device market in 2018. This dominance is linked to increased cancer prevalence, increased awareness of cancer screening, the existence of well-established healthcare facilities, and the presence of early tests and treatments in the region. The Europe market is expected to witness a CAGR of 4.9% during (2019 - 2025). The Asia- Pacific region is anticipated to experience the highest growth rate of 6.6% during the forecast period. This rapid growth rate can be attributed to extensive government initiatives, healthcare spending, cancer awareness campaigns, and the availability of technologically advanced smart biopsy devices.
Structural Insights: https://www.kbvresearch.com/smart-biopsy-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.
Unique Offerings from KBV Research